Neuropsychiatric symptoms of post-COVID-19 condition in Mexican healthcare personnel.

Authors

DOI:

https://doi.org/10.19136/hs.a23n1.5657

Abstract

Objective: The aim of the present study was to identify anxiety and depression in health personnel who suffered COVID-19, and to associate them with blood inflammatory markers.

Materials and methods: The design of this study was descriptive and cross-sectional. We evaluated 51 healthcare workers who survived COVID-19 disease with Hamilton scales for anxiety and depression, also we calculated inflammatory markers (systemic immune-inflammation index, SII; monocyte lymphocyte ratio, MLR; platelet lymphocyte ratio, PLR; and neutrophil lymphocyte ratio, NLR) using blood venous samples. This study was carried out from August 2021 to December 2022. Statistical analysis was performed using SPSS v. 26.

Results: Our study included 51 healthcare personnel, females (n=29) and males (n=22). The mean age was 40.54 ± 11.00 years. The most frequent acute symptoms for COVID-19 presented were dysgeusia (n=20), anosmia (n=18), and headache (n=17). The most common comorbidities were overweight (n=24), obesity (n=22), and hypertension (n=11). According to the Hamilton Rating Scale for Anxiety (HARS) and Hamilton Rating Scale for Depression Rating (HRSD) we identify anxiety and depression in 72.5% (n=37) and 51% (n=26) within the health personnel, respectively.

Conclusions: In our study, we observed a high frequency of anxiety and depression in healthcare workers with post COVID-19 condition. However, we did not observe an association between inflammatory markers (NLR, PLR, MLR, and SII) with anxiety and depression in health personnel post-COVID-19. We suggest follow-up assessments in healthcare personnel with post-COVID-19 condition, to evaluate if mixed emotional disorders persist.

Keywords: Anxiety; Depression; Mental disorders; Inflammation; COVID-19.

Downloads

Download data is not yet available.

Author Biographies

  • David Ruiz-Ramos, Universidad Juárez Autónoma de Tabasco

    Master in Biomedical Sciences. Academic Division of Health Sciences, Juárez Autonomous University of Tabasco.

     
  • Cecilia Yazmin Alonso-García , Universidad Juárez Autónoma de Tabasco

    Graduated in General Medicine. Academic Division of Health Sciences, Juárez Autonomous University of Tabasco.

     
  • Roberto Esteban Salazar-Rifka, High Specialty Hospital "Centennial of the Mexican Revolution",

    Epidemiology Residency Program. High Specialty Hospital "Centennial of the Mexican Revolution", Morelos, Mexico.

     
  • José Jaime Martínez-Magaña, Yale University School of Medicine, Facultad de Medicina de la Universidad de Yale

    Doctor in Biomedical Sciences. Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.

     
  • Germán Alberto Nolasco-Rosales, Universidad Juárez Autónoma de Tabasco

    Master in Biomedical Sciences. Academic Division of Health Sciences, Juárez Autonomous University of Tabasco; Villahermosa, Tabasco, Mexico.

     
  • Mario Villar-Soto, Hospital Regional de Alta Especialidad de Salud Mental, Hospital Regional de Alta Especialidad de Salud Mental

    Medical Specialist in Psychiatry. Mental Health Regional High Specialty Hospital, Villahermosa, Tabasco, Mexico.

     

Published

2023-12-16

Issue

Section

Research article

How to Cite

Ruiz-Ramos, D., Alonso-García , C. Y., Salazar-Rifka, R. E., Martínez-Magaña , J. J., Nolasco-Rosales, G. A., & Villar-Soto, M. (2023). Neuropsychiatric symptoms of post-COVID-19 condition in Mexican healthcare personnel. Horizonte Sanitario, 23(1), 11-19. https://doi.org/10.19136/hs.a23n1.5657